Antibody candidate for treating serious liver disease

Epsilogen completes first clinical trial of IgE antibody to treat cancer

In Depth 26 Jul 2023

Antibody drug conjugates: BiVictriX drives a new era in cancer medicine

Alchemab Therapeutics unveils Alzheimer’s candidate  

Clearance for anti-tumor bispecific antibody trial

BioNTech adds antibody-drug conjugates to cancer portfolio with potential $1.5B partnership deal

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

Merck and Kelun-Biotech collaborating on seven ADC cancer candidates 

Positive antibody persistence for vaccine treating mosquito disease

Bio-Rad introduces pioneer antibody discovery platform for therapeutic development